Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jens, Bedke"'
Purpose Immune-based (IO)-combinations are the backbone in the systemic therapy of metastatic renal cell carcinoma (mRCC). Despite phase III clinical trial data, real world data are of special importance to reflect clinical practice. Methods This ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a927a8233ccb386ea48fbb97cf445d54
https://doi.org/10.21203/rs.3.rs-1748237/v1
https://doi.org/10.21203/rs.3.rs-1748237/v1